These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21986108)

  • 1. Targeting heat shock response pathways to treat pancreatic cancer.
    Xia Y; Rocchi P; Iovanna JL; Peng L
    Drug Discov Today; 2012 Jan; 17(1-2):35-43. PubMed ID: 21986108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs in the treatment of pancreatic cancer.
    Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core signaling pathways and new therapeutic targets in pancreatic cancer.
    You L; Chen G; Zhao YP
    Chin Med J (Engl); 2010 May; 123(9):1210-5. PubMed ID: 20529565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targeting therapy for pancreatic cancer.
    Xiong HQ
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S69-77. PubMed ID: 15316751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting heat shock factor 1 with a triazole nucleoside analog to elicit potent anticancer activity on drug-resistant pancreatic cancer.
    Xia Y; Liu Y; Rocchi P; Wang M; Fan Y; Qu F; Iovanna JL; Peng L
    Cancer Lett; 2012 May; 318(2):145-53. PubMed ID: 22266185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
    Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
    Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the heat shock response in cancer: tipping the balance in transformed cells.
    Sanghera SS; Skitzki JJ
    Surg Oncol Clin N Am; 2013 Oct; 22(4):665-84. PubMed ID: 24012394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
    Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
    Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.
    Saleem M; Kaur S; Kweon MH; Adhami VM; Afaq F; Mukhtar H
    Carcinogenesis; 2005 Nov; 26(11):1956-64. PubMed ID: 15958516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-gene signaling pathways in pancreatic cancer.
    Drakaki A; Iliopoulos D
    Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
    Bisht S; Brossart P; Maitra A; Feldmann G
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Notch signaling in pancreatic cancer.
    Ristorcelli E; Lombardo D
    Expert Opin Ther Targets; 2010 May; 14(5):541-52. PubMed ID: 20392166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock proteins and the pancreas.
    Rakonczay Z; Takács T; Boros I; Lonovics J
    J Cell Physiol; 2003 Jun; 195(3):383-91. PubMed ID: 12704647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of pancreatic cancer and clinical perspectives.
    Matthaios D; Zarogoulidis P; Balgouranidou I; Chatzaki E; Kakolyris S
    Oncology; 2011; 81(3-4):259-72. PubMed ID: 22116519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel targets for pancreatic cancer therapy.
    Philip PA
    Surg Oncol Clin N Am; 2010 Apr; 19(2):419-29. PubMed ID: 20159523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.
    Walsh N; Larkin A; Swan N; Conlon K; Dowling P; McDermott R; Clynes M
    Cancer Lett; 2011 Jul; 306(2):180-9. PubMed ID: 21470770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
    Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
    Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates.
    Li M; Becnel LS; Li W; Fisher WE; Chen C; Yao Q
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):381-7. PubMed ID: 16314822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heat shock proteins: new target in cytoprotective and tumor therapy].
    Bao XQ; Liu GT
    Yao Xue Xue Bao; 2008 Mar; 43(3):234-40. PubMed ID: 18630257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.